Jinshi sub pharmaceutical: the shareholder Jiang Erchen plans to reduce 287000 shares
Financial Associated Press, August 19 - Jinshi Yayao announced that Jiang Erchen, a shareholder with a shareholding of 0.07%, plans to reduce 287000 shares of the company by means of centralized bidding from September 13, 2021 to March 13, 2022 (accounting for 0.07% of the total share capital of the company). Jiang Erchen is the person acting in concert of Lou Jin, the shareholder holding more than 5% of the company (calculated in concert).
This text is a result of machine translation.
Related companies：
In-depth
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Apr 02, 2022 05:34 PM
· Technology
China network security industry innovation and development alliance was officially established
Briefing Feb 25, 2022 09:18 AM
· Technology
Wheat continued to rise on the Chicago Board of trade, hitting its highest level since 2008.
Briefing Feb 24, 2022 10:09 PM
· Technology
Yishite: customers who have focused on data center business for many years include Tencent and Baidu
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Apr 23, 2024 02:21 PM